The abstract is read at the publisher; the summary is JClub's.
Cortical demyelination in multiple sclerosis has become a central pathological feature, with subpial and brain–cerebrospinal fluid interface inflammation linked to progression independent of relapse activity.
- Why it matters: Its biology, clinical importance, and treatment responsiveness are still not fully resolved, limiting how well clinicians can diagnose, prognosticate, and target this compartment.
- What they did: This Review synthesizes neuropathological and imaging evidence on cortical lesion frequency and heterogeneity, including meningeal inflammation and neuroaxonal injury, and evaluates emerging MRI methods plus biomarkers and artificial intelligence.
- The result: The evidence supports cortical pathology as biologically meaningful for disease course and suggests that quantitative MRI, fluid biomarkers, and AI could help define cortical endotypes and inform future therapies.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.